Compare PIM & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIM | QTRX |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 159.9M |
| IPO Year | N/A | 2017 |
| Metric | PIM | QTRX |
|---|---|---|
| Price | $2.99 | $2.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 63.3K | ★ 518.0K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | ★ 8.28% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $3.09 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | $60.00 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $2.95 | $2.13 |
| 52 Week High | $3.41 | $8.77 |
| Indicator | PIM | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 30.05 |
| Support Level | $2.96 | N/A |
| Resistance Level | $3.21 | $3.40 |
| Average True Range (ATR) | 0.04 | 0.29 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 0.00 | 9.92 |
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.